Report Summary:

Contraception, popularly known as birth control or fertility control, is used to prevent pregnancy. There are various temporary and permanent contraceptive methods and devices available in the market. Sterilization is a permanent method that almost eliminates the chances of pregnancy.

Temporary methods can either be hormonal or non-hormonal. Hormonal methods include oral contraceptive pills, contraceptive transdermal patches, vaginal rings, hormonal IUDs, and vaginal implants. These methods use synthetic sex hormones - estrogen, progestin, or a combination of both - to prevent ovulation and thicken the cervical mucus.

Non-hormonal methods include condoms, cervical caps, diaphragms, non-hormonal IUDs, sponges, and withdrawal methods. The report analysts forecast the global female contraceptive market to grow at a CAGR of 3.0% over the period 2014-2019.

Covered in this report:

This report covers the present scenario and the growth prospects of the global female contraceptive market for the period 2015-2019. This report considers 2014 as the base year and provides data for the trailing 12 months.

This report covers the following types of female contraceptive:

Devices (IUDs, Sterilization, Subdermal contraceptive implants, Vaginal rings, Female condoms, Non-surgical permanent contraception, Contraceptive diaphragms, and Contraceptive sponges)
Drugs (Birth control pills and Emergency pills)

To Read more reports of this category:
http://www.radiantinsights.com/catalog/retail

Global Female Contraceptive Market has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, APAC, and EMEA; it also covers the landscape of the global female contraceptive market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key region

• Americas
• APAC
• EMEA

Key vendors

• Allergan
• Merck
• Pfizer
• Teva Pharmaceutical

Other prominent vendros

• Ansell
• Church & Dwight
• Bayer
• Agile Therapeutics
• Caya
• Fuji Latex
• Janssen Pharmaceuticals
• HLL Lifecare
• Lipocine
• Mayer Laboratories
• Okamoto Industries
• Reckitt Benckiser Group
• Today Sponge
• Female Health

Key market driver

• Improved family planning
• For a full, detailed list, view our report

Key market challenge

• Lack of social acceptance
• For a full, detailed list, view our report

Key market trend

• Increased unplanned pregnancy
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?